<SEC-DOCUMENT>0001140361-21-035197.txt : 20211022
<SEC-HEADER>0001140361-21-035197.hdr.sgml : 20211022
<ACCEPTANCE-DATETIME>20211022160535
ACCESSION NUMBER:		0001140361-21-035197
CONFORMED SUBMISSION TYPE:	25
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20211022
DATE AS OF CHANGE:		20211022
EFFECTIVENESS DATE:		20211022

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		211340581

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>25
<SEQUENCE>1
<FILENAME>brhc10030006_25.htm
<DESCRIPTION>25
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"><font style="font-size: 14pt;">UNITED STATES</font></div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 25</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">NOTIFICATION OF REMOVAL FROM LISTING</div>
    <div style="text-align: center; font-weight: bold;">AND/OR REGISTRATION UNDER SECTION 12(b)</div>
    <div style="text-align: center; font-weight: bold;">OF THE SECURITIES EXCHANGE ACT OF 1934.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">Commission File Number: 001-11460</div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-size: 24pt; font-weight: bold;">Brooklyn ImmunoTherapeutics, Inc.</div>
    <div style="text-align: center; font-weight: bold;">NYSE American</div>
    <div style="text-align: center; font-weight: bold;">(Exact name of Issuer as specified in its charter, and name of Exchange</div>
    <div style="text-align: center; font-weight: bold;">where security is listed and/or registered)</div>
    <div> <br>
    </div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: center; font-weight: bold;">140 58th Street, Building A, Suite 2100</div>
    <div style="text-align: center; font-weight: bold;">Brooklyn, New York 11220</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(212) 582-1199</div>
    <div style="text-align: center; font-weight: bold;">(Address, including zip code, and telephone number, including area code, of Issuer&#8217;s principal executive offices)</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">Common stock, par value $0.005 per share</div>
    <div style="text-align: center; font-weight: bold;">(Description of class of securities)</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div>&#160;</div>
    <div>Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:</div>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc56e1c88922b4a5599f6298db3fc858c">

        <tr>
          <td style="width: 17.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">17 CFR 240.12d2-2(a)(1)</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: -17.5pt; margin-left: 18pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0faf2ef1aacc424ea91df028812d33af">

        <tr>
          <td style="width: 17.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">17 CFR 240.12d2-2(a)(2)</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: -17.5pt; margin-left: 18pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z290aa29e81f445d0adcba1262b1ec1ff">

        <tr>
          <td style="width: 17.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">17 CFR 240.12d2-2(a)(3)</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: -17.5pt; margin-left: 18pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdd7d75a5aa6e4f5bac1c21a52f787d58">

        <tr>
          <td style="width: 17.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">17 CFR 240.12d2-2(a)(4)</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: -17.5pt; margin-left: 18pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze0821878068e4fcbb6d76a814a658490">

        <tr>
          <td style="width: 17.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
        </tr>

    </table>
    <div style="text-indent: -17.5pt; margin-left: 18pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z170fcbc33eb44b099b034f813da8f7c0">

        <tr>
          <td style="width: 17.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing
              and registration on the Exchange.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, Brooklyn ImmunoTherapeutics, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this
      notification to be signed on its behalf by the undersigned duly authorized person.</div>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1a2eee88c811462a930e3317352d7332">

        <tr>
          <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">October 22, 2021</div>
            </div>
          </td>
          <td style="width: 4.05%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">By</div>
          </td>
          <td style="width: 30.16%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">/s/ Howard J. Federoff</div>
            </div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 30.16%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Chief Executive Officer and President</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Date</div>
          </td>
          <td style="width: 4.05%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 30.16%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 30.16%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title</div>
          </td>
        </tr>

    </table>
    <div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc4d162661c5419bae01c891366d15eb">

        <tr>
          <td style="width: 17.5pt; vertical-align: top;"><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Form 25 and attached notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
